Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracoronary Administration of Levosimendan in Cardiac Surgery Patients

NCT01500785 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracoronary Administration of Levosimendan in Cardiac Surgery Patients
Lead sponsor
Tampere University Hospital
Phase
Phase 4
Overall status
Terminated
Start date
June 15, 2018
Completion date
September 11, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.